Revenue Growth Stock Market Corporate Finance Investments Market Trends Investment Artificial Intelligence Tariffs Market Dynamics Corporate Earnings
The acquisition strengthens GSK's hepatology pipeline with a potential best-in-class treatment targeting a 2029 market launch.